Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden · Delayed Price · Currency is SEK 10.86
+0.08 (0.74%)
Sep 24, 2025, 5:29 PM CET
Diamyd Medical AB Market Cap
Diamyd Medical AB has a market cap or net worth of 1.49 billion as of September 24, 2025. Its market cap has decreased by -4.50% in one year.
Market Cap
1.49B
Enterprise Value
1.17B
Revenue
129.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.86
Market Cap Chart
Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 1.49B, an increase of 1,026.86%. That is a compound annual growth rate of 21.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2025 | 1.48B | -13.38% |
| Dec 30, 2024 | 1.71B | 182.47% |
| Dec 29, 2023 | 605.80M | -41.10% |
| Dec 30, 2022 | 1.03B | -9.66% |
| Dec 30, 2021 | 1.14B | -46.65% |
| Dec 30, 2020 | 2.13B | 23.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 96.74B |
| Sectra AB | 60.57B |
| Getinge AB | 58.40B |
| Camurus AB | 40.67B |
| Medicover AB | 39.78B |
| Asker Healthcare Group AB | 34.05B |
| BioArctic AB | 25.16B |
| AddLife AB | 23.00B |